CAS
VCYT icon

Coppell Advisory Solutions’s Veracyte VCYT Stock Holding History

Coppell Advisory Solutions’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-671
Closed -$22.7K – 2082
2024
Q3 		$22.7K Buy
+671
New +$18.9K ﹤0.01% 821
2023
Q4 		$825 Buy
+30
New +$724 ﹤0.01% 1445

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Coppell Advisory Solutions's VCYT Position: Q4 2024 in Review

Coppell Advisory Solutions sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 671 shares — an estimated $22.7K sold.

Coppell Advisory Solutions first reported a position in VCYT in Q4 2023 and held it in 2 quarters. The position peaked at $22.7K in Q3 2024. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

  • Coppell Advisory Solutions reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
  • Coppell Advisory Solutions sold 671 Veracyte shares in Q4 2024, an estimated $22.7K.
  • Coppell Advisory Solutions first reported a position in Veracyte in Q4 2023 and held it in 2 quarters.
  • Coppell Advisory Solutions's Veracyte position peaked at $22.7K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Coppell Advisory Solutions's 13F filing for Q4 2024, filed 14 Feb 2025.